MétaCan
Menu
Back to cohort
Record W4405838583 · doi:10.1097/cxa.0000000000000221

Unanticipated Benzodiazepine Withdrawal in the Context of an Adulterated Unregulated Opioid Supply in Vancouver, BC: A Case Series

2024· article· en· W4405838583 on OpenAlex
Matthew K. Laing, Nicole Cowan, Paxton Bach, Valerie Giang

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.
venuePublished in a venue whose home country is Canada.
aboutThe title or abstract carries a Canadian signal from the geographic lexicon.

Bibliographic record

VenueThe Canadian Journal of Addiction · 2024
Typearticle
Languageen
FieldMedicine
TopicAlcoholism and Thiamine Deficiency
Canadian institutionsVancouver Coastal HealthBritish Columbia Centre on Substance UseUniversity of British Columbia
Fundersnot available
KeywordsBenzodiazepineDiscontinuationMedicineContext (archaeology)AnesthesiaDiazepamOpioidMedical prescriptionPsychiatryInternal medicinePharmacology

Abstract

fetched live from OpenAlex

ABSTRACT Background: Novel psychoactive substance (NPS) benzodiazepines have emerged as frequent adulterants of the unregulated opioid supply in Vancouver, BC. People regularly and inadvertently exposed to these adulterants who abruptly discontinue unregulated opioid use may be at elevated risk for unanticipated benzodiazepine withdrawal. Objective: To explore the phenomenon of unanticipated benzodiazepine withdrawal in a medically supervised setting for people undergoing withdrawal management for opioid use disorder. Methods: Chart-based retrospective case series (n=6) of people with severe opioid use disorder and without a history of co-occurring alcohol use or intentional benzodiazepine use, presenting to a medically supervised withdrawal management facility, who exhibited signs consistent with unanticipated benzodiazepine withdrawal during admission. Results: The average length of stay was 7.1 days (range=5–10), with 2/6 patients requiring transfer to the hospital related to suspected benzodiazepine withdrawal, and 5/6 being discharged following stabilization of suspected benzodiazepine withdrawal. Peak Clinical Institute Withdrawal Assessment Alcohol Scale Revised scores ranged from 12 to 26 (mean=16.8), with 1 patient exhibiting a withdrawal-related seizure, 5 experiencing acute perceptual disturbances, and zero fatalities recorded. Heterogeneity was observed in the timing and presentation of suspected benzodiazepine withdrawal. The average total administered benzodiazepine dose in diazepam equivalents was 90.8 mg (range=30–150 mg) over an average of 3.8 days. Conclusions: Where drug markets are characterized by high rates of NPS benzodiazepine adulteration, people undergoing abrupt discontinuation of unregulated opioids in a range of settings—including those accessing withdrawal management services—may be at elevated risk for complicated benzodiazepine withdrawal. Standardized risk assessment and management approaches are needed to address these potential harms and monitor for evolution of adulteration-associated trends. Contexte: Les benzodiazépines, nouvelles substances psychoactives (NSP), sont devenues des adultérants fréquents dans l’approvisionnement non réglementé en opioïdes à Vancouver, C.-B. Les personnes exposées régulièrement par inadvertance à ces adultérants qui cessent brusquement d’utiliser des opioïdes non réglementés peuvent être exposées à un risque élevé de sevrage imprévu des benzodiazépines. Objectif: Explorer le phénomène du sevrage imprévu des benzodiazépines dans un cadre médical supervisé pour les personnes en cours de gestion du sevrage pour un trouble de l’utilisation des opioïdes (TUO). Méthodes: Série de cas rétrospectifs basés sur des dossiers (n=6) de personnes souffrant d’un TUO sans antécédents de consommation concomitante d’alcool ou de consommation intentionnelle de benzodiazépines, se présentant à un centre de gestion du sevrage sous surveillance médicale et présentant des signes compatibles avec un sevrage non anticipé de benzodiazépines pendant l’admission. Résultats: La durée moyenne du séjour était de 7,1 jours (intervalle=5-10), 2/6 patients ayant nécessité un transfert à l’hôpital en raison d’un sevrage suspect de benzodiazépines, et 5/6 ayant été libérés après stabilisation du sevrage suspect de benzodiazépines. Les scores du Peak Clinical Institute Withdrawal Assessment Alcohol Scale Revised (CIWA-Ar) allaient de 12 à 26 (moyenne=16,8), un patient ayant présenté une crise liée au sevrage, cinq ayant souffert de troubles perceptifs aigus, et aucun décès n’ayant été enregistré. Une hétérogénéité a été observée dans le moment et la présentation des cas présumés de sevrage aux benzodiazépines. La dose moyenne totale de benzodiazépines administrée en équivalents diazépam était de 90,8 mg (intervalle=30-150 mg) sur une moyenne de 3,8 jours. Conclusions: Lorsque les marchés de la drogue sont caractérisés par des taux élevés d’altération par des benzodiazépines (NSP), les personnes qui subissent un arrêt brutal des opioïdes non réglementés dans divers contextes - y compris celles qui ont accès à des services de gestion du sevrage - peuvent être exposées à un risque élevé de sevrage complexe aux benzodiazépines. Des approches normalisées d'évaluation et de gestion des risques sont nécessaires pour faire face à ces dommages potentiels et surveiller l'évolution des tendances associées à l’adultération.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Case report · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.614
Threshold uncertainty score0.932

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.256
Teacher spread0.243 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it